Annual Total Liabilities
$53.20 B
-$4.83 B-8.33%
31 December 2023
Summary:
Novartis AG annual total liabilities is currently $53.20 billion, with the most recent change of -$4.83 billion (-8.33%) on 31 December 2023. During the last 3 years, it has fallen by -$17.92 billion (-25.20%). NVS annual total liabilities is now -25.20% below its all-time high of $71.11 billion, reached on 31 December 2020.NVS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$60.08 B
+$4.48 B+8.06%
30 September 2024
Summary:
Novartis AG quarterly total liabilities is currently $60.08 billion, with the most recent change of +$4.48 billion (+8.06%) on 30 September 2024. Over the past year, it has dropped by -$14.37 billion (-19.30%). NVS quarterly total liabilities is now -33.71% below its all-time high of $90.64 billion, reached on 31 March 2019.NVS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.3% | -19.3% |
| 3 y3 years | -25.2% | -6.5% |
| 5 y5 years | -20.4% | -5.2% |
NVS Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -25.2% | at low | -19.3% | +12.9% |
| 5 y | 5 years | -25.2% | at low | -20.0% | +12.9% |
| alltime | all time | -25.2% | +303.9% | -33.7% | +356.2% |
Novartis AG Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $60.08 B(+8.1%) |
| June 2024 | - | $55.60 B(+1.9%) |
| Mar 2024 | - | $54.58 B(+2.6%) |
| Dec 2023 | $53.20 B(-8.3%) | $53.20 B(-28.6%) |
| Sept 2023 | - | $74.45 B(+26.1%) |
| June 2023 | - | $59.05 B(-1.7%) |
| Mar 2023 | - | $60.10 B(+3.6%) |
| Dec 2022 | $58.03 B(-9.3%) | $58.03 B(+0.8%) |
| Sept 2022 | - | $57.57 B(-3.9%) |
| June 2022 | - | $59.90 B(-5.7%) |
| Mar 2022 | - | $63.51 B(-0.7%) |
| Dec 2021 | $63.97 B(-10.0%) | $63.97 B(-0.5%) |
| Sept 2021 | - | $64.27 B(-8.0%) |
| June 2021 | - | $69.89 B(-1.8%) |
| Mar 2021 | - | $71.16 B(+0.1%) |
| Dec 2020 | $71.11 B(+13.2%) | $71.11 B(-5.3%) |
| Sept 2020 | - | $75.12 B(+7.5%) |
| June 2020 | - | $69.88 B(-3.1%) |
| Mar 2020 | - | $72.12 B(+14.8%) |
| Dec 2019 | $62.82 B(-6.1%) | $62.82 B(-0.9%) |
| Sept 2019 | - | $63.37 B(-2.2%) |
| June 2019 | - | $64.79 B(-28.5%) |
| Mar 2019 | - | $90.64 B(+35.5%) |
| Dec 2018 | $66.87 B(+13.6%) | $66.87 B(+2.9%) |
| Sept 2018 | - | $64.97 B(-0.3%) |
| June 2018 | - | $65.16 B(+1.3%) |
| Mar 2018 | - | $64.31 B(+9.3%) |
| Dec 2017 | $58.85 B(+6.6%) | $58.85 B(-6.0%) |
| Sept 2017 | - | $62.60 B(-1.8%) |
| June 2017 | - | $63.77 B(-0.9%) |
| Mar 2017 | - | $64.34 B(+16.5%) |
| Dec 2016 | $55.23 B(+1.5%) | $55.23 B(-6.3%) |
| Sept 2016 | - | $58.94 B(+0.1%) |
| June 2016 | - | $58.90 B(-2.7%) |
| Mar 2016 | - | $60.56 B(+11.3%) |
| Dec 2015 | $54.43 B(-0.2%) | $54.43 B(-3.0%) |
| Sept 2015 | - | $56.14 B(-0.8%) |
| June 2015 | - | $56.58 B(-3.3%) |
| Mar 2015 | - | $58.49 B(+7.2%) |
| Dec 2014 | $54.54 B(+5.3%) | $54.54 B(+1.1%) |
| Sept 2014 | - | $53.95 B(-2.3%) |
| June 2014 | - | $55.25 B(+0.5%) |
| Mar 2014 | - | $55.00 B(+6.2%) |
| Dec 2013 | $51.78 B(-5.7%) | $51.78 B(-1.2%) |
| Sept 2013 | - | $52.41 B(+1.9%) |
| June 2013 | - | $51.44 B(-4.5%) |
| Mar 2013 | - | $53.86 B(-1.9%) |
| Dec 2012 | $54.93 B | $54.93 B(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $54.01 B(-0.4%) |
| June 2012 | - | $54.25 B(-3.5%) |
| Mar 2012 | - | $56.21 B(+9.0%) |
| Dec 2011 | $51.56 B(-3.7%) | $51.56 B(-6.7%) |
| Sept 2011 | - | $55.24 B(-6.1%) |
| June 2011 | - | $58.82 B(-4.9%) |
| Mar 2011 | - | $61.88 B(+15.6%) |
| Dec 2010 | $53.55 B(+40.8%) | $53.55 B(-8.3%) |
| Sept 2010 | - | $58.41 B(+42.1%) |
| June 2010 | - | $41.11 B(+1.3%) |
| Mar 2010 | - | $40.58 B(+6.7%) |
| Dec 2009 | $38.04 B(+36.5%) | $38.04 B(+1.8%) |
| Sept 2009 | - | $37.37 B(+10.6%) |
| June 2009 | - | $33.79 B(+6.4%) |
| Mar 2009 | - | $31.74 B(+13.9%) |
| Dec 2008 | $27.86 B(+6.9%) | $27.86 B(-10.9%) |
| Sept 2008 | - | $31.28 B(-1.6%) |
| June 2008 | - | $31.79 B(+17.5%) |
| Mar 2008 | - | $27.05 B(+3.8%) |
| Dec 2007 | $26.06 B(-2.5%) | $26.06 B(-5.1%) |
| Sept 2007 | - | $27.44 B(+1.8%) |
| June 2007 | - | $26.96 B(-3.1%) |
| Mar 2007 | - | $27.82 B(+4.1%) |
| Dec 2006 | $26.71 B(+8.7%) | $26.71 B(-5.5%) |
| Sept 2006 | - | $28.27 B(-1.7%) |
| June 2006 | - | $28.77 B(+14.6%) |
| Mar 2006 | - | $25.09 B(+2.1%) |
| Dec 2005 | $24.57 B(+16.0%) | $24.57 B(+7.1%) |
| Sept 2005 | - | $22.93 B(+1.2%) |
| June 2005 | - | $22.65 B(+12.2%) |
| Mar 2005 | - | $20.18 B(-4.7%) |
| Dec 2004 | $21.17 B(+12.6%) | $21.17 B(+15.0%) |
| Sept 2004 | - | $18.41 B(+0.1%) |
| June 2004 | - | $18.39 B(-2.9%) |
| Mar 2004 | - | $18.94 B(+0.8%) |
| Dec 2003 | $18.80 B(+12.6%) | $18.80 B(+5.1%) |
| Sept 2003 | - | $17.89 B(-6.9%) |
| June 2003 | - | $19.22 B(+3.1%) |
| Mar 2003 | - | $18.65 B(+11.7%) |
| Dec 2002 | $16.69 B(+13.2%) | $16.69 B(+9.4%) |
| Sept 2002 | - | $15.25 B(+0.7%) |
| June 2002 | - | $15.14 B(+2.7%) |
| Dec 2001 | $14.75 B(+12.0%) | $14.75 B(+5.9%) |
| June 2001 | - | $13.92 B(+5.7%) |
| Dec 2000 | $13.17 B(-25.3%) | $13.17 B(-15.5%) |
| June 2000 | - | $15.58 B |
| Dec 1999 | $17.64 B(-1.5%) | - |
| Dec 1998 | $17.90 B | - |
FAQ
- What is Novartis AG annual total liabilities?
- What is the all time high annual total liabilities for Novartis AG?
- What is Novartis AG annual total liabilities year-on-year change?
- What is Novartis AG quarterly total liabilities?
- What is the all time high quarterly total liabilities for Novartis AG?
- What is Novartis AG quarterly total liabilities year-on-year change?
What is Novartis AG annual total liabilities?
The current annual total liabilities of NVS is $53.20 B
What is the all time high annual total liabilities for Novartis AG?
Novartis AG all-time high annual total liabilities is $71.11 B
What is Novartis AG annual total liabilities year-on-year change?
Over the past year, NVS annual total liabilities has changed by -$4.83 B (-8.33%)
What is Novartis AG quarterly total liabilities?
The current quarterly total liabilities of NVS is $60.08 B
What is the all time high quarterly total liabilities for Novartis AG?
Novartis AG all-time high quarterly total liabilities is $90.64 B
What is Novartis AG quarterly total liabilities year-on-year change?
Over the past year, NVS quarterly total liabilities has changed by -$14.37 B (-19.30%)